You have 9 free searches left this month | for more free features.

HIV drug resistance

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

Not yet recruiting
  • Hiv
  • +5 more
  • differences in CD4 reconstruction
  • (no location specified)
Sep 17, 2023

Large Scale Transition toDolutegravir-based First-line ART in

Not yet recruiting
  • HIV Infections
    • Abidjan, Côte D'Ivoire
    • +2 more
    Mar 28, 2022

    HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

    Not yet recruiting
    • HIV
    • +2 more
    • Basel, Switzerland
    • +6 more
    Sep 7, 2023

    Emergence of HIV Drug Resistance Following Initiation of TLD

    Recruiting
    • HIV-1-infection
      • Port-au-Prince, Bicentaire, Haiti
      • +13 more
      Feb 22, 2022

      HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)

      Completed
      • HIV/AIDS
      • Intensified monitoring
      • Standard of care monitoring
      • Elandsdoorn, Limpopo, South Africa
        Ndlovu Medical Centre
      May 10, 2022

      HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))

      Not yet recruiting
      • HIV/AIDS
      • Intensive Adherence Counselling (IAC)
      • Masaka, Uganda
        Kalisizo Hospital
      Aug 22, 2022

      HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

      Terminated
      • HIV-1-infection
      • Biktarvy Tab
      • Saint Louis, Missouri
        Southampton Healthcare, Inc.
      Jan 3, 2023

      HIV Drug Resistance Pattern Due to Migration in Poland

      Not yet recruiting
      • HIV Infections
      • +2 more
      • HIV drug resistance testing
      • Warsaw, Mazowia, Poland
        Department of Infectious Diseases, Tropical Diseases and Hepatol
      Nov 20, 2020

      Medication Adherence, HIV Drug Resistance Trial in Harare (Adapted Nzira Itsva)

      Withdrawn
      • Medication Adherence
      • HIV Drug Resistance
      • Adapted Nzira Itsva
      • Harare, Zimbabwe
        University of Zimbabwe
      Nov 23, 2020

      ANRS 12406 EvvA Study

      Recruiting
      • HIV-1-infection
        • Douala, Cameroon
          Hôpital Laquinitie de Douala
        Apr 29, 2021

        Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA

        Recruiting
        • HIV-1-infection
        • Genotypic Resistance Test
        • Paris, France
          ARVD
        Jul 21, 2021

        Virologic Failure and Drug Resistance at and After Switching to

        Active, not recruiting
        • Hiv
        • +2 more
          • Lilongwe, Malawi
          • +1 more
          Feb 14, 2022

          HIV Positive Trial in Maseno, Nairobi (Pre-ART Oligonucleotide Assay (OLA))

          Completed
          • HIV Positive
          • Pre-ART Oligonucleotide Assay (OLA)
          • Maseno, Kenya
          • +1 more
          Oct 18, 2021

          HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

          Recruiting
          • HIV-1-infection
          • Multi-Antiviral Resistance
          • REGISTER CREATION
          • Milan, MI, Italy
            Ospedale San Raffaele
          Dec 22, 2021

          New Treatment Strategies in Eastern European Region and in

          Recruiting
          • HIV-1-infection
            • Cologne, Germany
            • +3 more
            Nov 10, 2023

            HIV-1 Resistance at Screening for HIV Prevention Studies

            Completed
            • HIV
              • Durban, KwaZulu Natal, South Africa
              • +6 more
              Jun 17, 2021

              HIV, Drug, Resistance Trial (Tenofovir Disoproxil)

              Unknown status
              • HIV
              • +2 more
              • Tenofovir Disoproxil
              • (no location specified)
              Jul 22, 2020

              HIV-1-infection, Inflammation, AIDS Trial in Worldwide

              Not yet recruiting
              • HIV-1-infection
              • +2 more
                • Brussels, Belgium
                • +24 more
                Jun 13, 2022

                HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

                Active, not recruiting
                • HIV-1-infection
                • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
                • Antwerp, Belgium
                • +28 more
                May 23, 2022

                Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

                Not yet recruiting
                • Multi-Drug Resistant Hiv-1 Infection
                • HIV-1 Infection
                • UB-421
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Feb 2, 2023

                HIV-1-infection Trial in Barcelona (Doravirine 100Mg Tab)

                Not yet recruiting
                • HIV-1-infection
                • Doravirine 100Mg Tab
                • Barcelona, Spain
                  Hospital Clinic i Provincial de Barcelona
                Aug 17, 2022

                HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

                Not yet recruiting
                • HIV
                • HIV Infections
                • (no location specified)
                Aug 4, 2023

                Mycoplasma Genitalium Infection and Associated Antimicrobial

                Not yet recruiting
                • STI
                • Mycoplasma Genitalium Infection
                • self-sampling kits for STI testing in the laboratory
                • Hong Kong, Hong Kong, China, Hong Kong
                  The Chinese University of Hong Kong
                Mar 16, 2023

                HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)

                Active, not recruiting
                • HIV-1-infection
                • Clinical management informed by HIV-1 genotypic resistance testing
                • Seboche, Butha-Buthe, Lesotho
                • +9 more
                Dec 4, 2022